Back
Ascendis Pharma AS Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
ASND
Ascendis Pharma AS
Last Price:
130.01
Seasonality Move:
20.86%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Ascendis Pharma AS Price Quote
$130.01
+0.20 (+6.01%)
(Updated: November 23, 2024 at 5:25 AM ET)
Ascendis Pharma AS Key Stats
Sell
27
Ascendis Pharma AS (ASND)
is a Sell
Day range:
$122.64 - $130.28
52-week range:
$90.13 - $161.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.88
P/B ratio:
0%
Volume:
380.3K
Avg. volume:
431.7K
1-year change:
39.58%
Market cap:
$7.8B
Revenue:
$288.8M
EPS:
$-8.11
How Much Does Ascendis Pharma AS Make?
-
How Much Are Ascendis Pharma AS's Sales Annually?
ASND Revenues are $288.8M -
How Much Profit Does Ascendis Pharma AS's Make A Year?
ASND net income is -$521.2M
Is Ascendis Pharma AS Growing As A Company?
-
What Is Ascendis Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22% -
What Is Ascendis Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ascendis Pharma AS Stock Price Performance
-
Did Ascendis Pharma AS Stock Go Up Last Month?
Ascendis Pharma AS share price went up by 0.57% last month -
Did ASND's Share Price Rise Over The Last Year?
ASND share price rose by 39.58% over the past 1 year
What Is Ascendis Pharma AS 52-Week High & Low?
-
What Is Ascendis Pharma AS’s 52-Week High Share Price?
Ascendis Pharma AS has traded as high as $161.00 over the past 52 weeks -
What Is Ascendis Pharma AS’s 52-Week Low Share Price?
Ascendis Pharma AS has traded as low as $90.13 over the past 52 weeks
Ascendis Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ascendis Pharma AS?
-
How Much Debt Does Ascendis Pharma AS Have?
Total long term debt quarterly is $880.9M -
How Much Cash Does Ascendis Pharma AS Have?
Cash and short term investments quarterly total is $698.6M -
What Is Ascendis Pharma AS’s Book Value Per Share?
Book value per share is -1.82
Is Ascendis Pharma AS Cash Flow Positive?
Data Unavailable
Ascendis Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ASND return on invested capital is -89.94% -
What Is Ascendis Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -48.84% -
What Is ASND Return On Equity?
ROE is a measure of profitability and is 0%
Ascendis Pharma AS Earnings Date & Stock Price
-
What Is Ascendis Pharma AS's Stock Price Today?
A single share of ASND can be purchased today for 129.81 -
What Is Ascendis Pharma AS’s Stock Symbol?
Ascendis Pharma AS trades on the nasdaq under the ticker symbol: ASND -
When Is Ascendis Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Ascendis Pharma AS is scheduled on February 7, 2025 -
When Is ASND's next ex-dividend date?
Ascendis Pharma AS's next ex-dividend date is November 24, 2024 -
How To Buy Ascendis Pharma AS Stock?
You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ascendis Pharma AS Competitors
-
Who Are Ascendis Pharma AS's Competitors?
Below is a list of companies who compete with Ascendis Pharma AS or are related in some way:
Ascendis Pharma AS Dividend Yield
-
What Is ASND Dividend Yield?
Ascendis Pharma AS’s dividend yield currently is 0% -
What Is Ascendis Pharma AS’s Payout Ratio?
Ascendis Pharma AS’s payout ratio is 0% -
When Did Ascendis Pharma AS Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Ascendis Pharma AS’s Dividend Per Share?
Ascendis Pharma AS pays a dividend of $0.00 per share
Ascendis Pharma AS Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -14.45% |
| Revenue: | 21.62% | -16.51% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 191.61 |
| Upside from Last Price: | 47.61% |